Page last updated: 2024-10-30

mesalamine and Pseudotumor Cerebri

mesalamine has been researched along with Pseudotumor Cerebri in 3 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).

Research Excerpts

ExcerptRelevanceReference
" Headaches initially improved but the dosage could not be decreased under 750 mg a day without recurrence of the symptoms."1.48Mesalazine treatment causing resolution of intracranial hypertension secondary to ulcerative colitis: A case report. ( Hage, A; Hage, R; Khanna, RK; Polin, V; Sené, T; Vignal-Clermont, C, 2018)
"To report a case of benign intracranial hypertension related to mesalazine use."1.32Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis. ( Giamundo, A; Iaccarino, G; Jura, A; Romano, A; Rosa, N, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khanna, RK1
Hage, R1
Hage, A1
Polin, V1
Sené, T1
Vignal-Clermont, C1
Rosa, N1
Giamundo, A1
Jura, A1
Iaccarino, G1
Romano, A1
Rottembourg, D1
Labarthe, F1
Arsene, S1
Jonville-Béra, AP1
Maurage, C1
Rolland, JC1

Other Studies

3 other studies available for mesalamine and Pseudotumor Cerebri

ArticleYear
Mesalazine treatment causing resolution of intracranial hypertension secondary to ulcerative colitis: A case report.
    Medicine, 2018, Volume: 97, Issue:49

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Humans; Male;

2018
Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis.
    American journal of ophthalmology, 2003, Volume: 136, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Headache; Humans; Mesal

2003
Headache during mesalamine therapy: a case report of mesalamine-induced pseudotumor cerebri.
    Journal of pediatric gastroenterology and nutrition, 2001, Volume: 33, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Female; Headache; Humans; Mesalamine; Pseudotumor Ce

2001